Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-label use in Japan
Masayuki Kubo, Kazuya Sakai, Yumi Yoshii, Masaki Hayakawa, Masanori Matsumoto
Topics & Concepts
RituximabMedicineInternal medicineADAMTS13Thrombotic thrombocytopenic purpuraThrombocytopenic purpuraRefractory (planetary science)GastroenterologyAutoantibodyCD20HematologySurgeryImmunologyAntibodyPlateletLymphomaPhysicsAstrobiologyComplement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaPlatelet Disorders and Treatments